Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04849364
Title Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bryan Schneider, MD
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Recruiting Birmingham Alabama 35294 United States Details
Georgetown University Recruiting Washington District of Columbia 20057 United States Details
Memorial Healthcare System Recruiting Hollywood Florida 33028 United States Details
Miami Cancer Institute at Baptist Health, Inc. Recruiting Miami Florida 33176 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Recruiting Indianapolis Indiana 46202 United States Details
Summit Health Recruiting Berkeley Heights New Jersey 07922 United States Details
Novant Health Cancer Institute Recruiting Winston-Salem North Carolina 27103 United States Details
Mays Cancer Center at UT Health San Antonio Recruiting San Antonio Texas 78229 United States Details
University of Wisconsin Recruiting Madison Wisconsin 53705 United States Details
Froedtert and The Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
Aurora Cancer Care Recruiting Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field